FI922343A - Förfarande för framställning av terapeutiskt användbara piperidin- och pyrrolidinderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara piperidin- och pyrrolidinderivat Download PDF

Info

Publication number
FI922343A
FI922343A FI922343A FI922343A FI922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A
Authority
FI
Finland
Prior art keywords
preparation
independently
therapeutically useful
pyrrolidine derivatives
piperidine
Prior art date
Application number
FI922343A
Other languages
English (en)
Finnish (fi)
Other versions
FI95026C (sv
FI922343A0 (sv
FI95026B (sv
Inventor
David Alker
Peter Edward Cross
Alexander Roderick Mackenzie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI922343A publication Critical patent/FI922343A/sv
Publication of FI922343A0 publication Critical patent/FI922343A0/sv
Application granted granted Critical
Publication of FI95026B publication Critical patent/FI95026B/sv
Publication of FI95026C publication Critical patent/FI95026C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI922343A 1990-01-06 1992-05-22 Förfarande för framställning av terapeutiskt användbara piperidin- och pyrrolidinderivat FI95026C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909000304A GB9000304D0 (en) 1990-01-06 1990-01-06 Muscarinic receptor antagonists
GB9000304 1990-01-06
PCT/EP1990/002041 WO1991010647A1 (en) 1990-01-06 1990-11-28 Muscarinic receptor antagonists
EP9002041 1990-11-28

Publications (4)

Publication Number Publication Date
FI922343A true FI922343A (sv) 1992-05-22
FI922343A0 FI922343A0 (sv) 1992-05-22
FI95026B FI95026B (sv) 1995-08-31
FI95026C FI95026C (sv) 1995-12-11

Family

ID=10668925

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922343A FI95026C (sv) 1990-01-06 1992-05-22 Förfarande för framställning av terapeutiskt användbara piperidin- och pyrrolidinderivat

Country Status (11)

Country Link
EP (1) EP0508988B1 (sv)
JP (1) JPH0657693B2 (sv)
AT (1) ATE102183T1 (sv)
DE (1) DE69007126T2 (sv)
DK (1) DK0508988T3 (sv)
ES (1) ES2063381T3 (sv)
FI (1) FI95026C (sv)
GB (1) GB9000304D0 (sv)
IE (1) IE63691B1 (sv)
PT (1) PT96419B (sv)
WO (1) WO1991010647A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280532B6 (cs) * 1990-10-10 1996-02-14 Schering Corporation Pyridinové a pyridin-N-oxidové deriváty diaryl-methyl-piperidinů nebo piperazinů, jejich použití a způsob jejich přípravy, farmaceutický prostředek je obsahující
JPH07505393A (ja) * 1992-03-27 1995-06-15 シェリング・コーポレーション 非橋渡しビスアリールカルビノール誘導体，組成物および使用法
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
WO1998047901A1 (en) * 1997-04-18 1998-10-29 Takeda Chemical Industries, Ltd. Process for producing tricyclic compounds and their intermediates
JP4767842B2 (ja) * 2003-04-01 2011-09-07 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
US7368463B2 (en) * 2003-07-11 2008-05-06 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
WO2005037280A1 (en) * 2003-10-14 2005-04-28 Glaxo Group Limited Muscarinic acetycholine receptor antagonists
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
EP1725525A1 (en) * 2004-03-11 2006-11-29 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
EP1723142A1 (en) * 2004-03-11 2006-11-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76583A (en) * 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents

Also Published As

Publication number Publication date
FI95026C (sv) 1995-12-11
JPH05501554A (ja) 1993-03-25
IE910019A1 (en) 1991-07-17
ATE102183T1 (de) 1994-03-15
EP0508988A1 (en) 1992-10-21
DK0508988T3 (da) 1994-05-09
GB9000304D0 (en) 1990-03-07
ES2063381T3 (es) 1995-01-01
FI922343A0 (sv) 1992-05-22
FI95026B (sv) 1995-08-31
PT96419A (pt) 1991-10-15
EP0508988B1 (en) 1994-03-02
DE69007126D1 (de) 1994-04-07
PT96419B (pt) 1998-06-30
DE69007126T2 (de) 1994-06-01
JPH0657693B2 (ja) 1994-08-03
WO1991010647A1 (en) 1991-07-25
IE63691B1 (en) 1995-05-31

Similar Documents

Publication Publication Date Title
CA2067817A1 (en) Muscarinic receptor antagonists
US5096890B1 (en) Pyrrolidine derivatives
FI922345A0 (sv) Förfarande för framställning av terapeutiskt användbara 3-substituerade pyrrolidinderivat
FI922343A0 (sv) Förfarande för framställning av terapeutiskt användbara piperidin- och pyrrolidinderivat
FI97468B (sv) Förfarande för framställning av terapeutiskt aktiv piperidinderivat
FI922346A (fi) Muscarinreceptorantagonister.

Legal Events

Date Code Title Description
BB Publication of examined application